Literature DB >> 18285291

Weight loss in patients with Alzheimer's disease.

Bruce K Tamura1, Kamal H Masaki, Patricia Blanchette.   

Abstract

Weight loss occurs frequently in patients with Alzheimer's disease (AD). This article will review why weight loss is so important in AD patients and what the ramifications are. This includes not only the negative effects of weight loss but possible benefits of weight gain. There is some evidence that weight loss manifests before AD. Structural, genetic, and neurochemical factors are discussed. There are possible risk factors and predictors which could herald weight loss in AD. Olfactory changes which occur in AD patients may make the food less appealing. Changes in food consumption may occur in AD leading to decreased energy intake. At the same time there is more evidence that increased energy expenditure is not the cause of weight loss in AD. Lastly we will go over possible treatment strategies. This includes environmental changes, food alterations, oral supplementations, and medications. A Medline literature search was conducted from 2000 to present using key search words of weight loss and Alzheimer's disease. Studies that were included were prospective designs, observational studies, review articles and their references.

Entities:  

Mesh:

Year:  2007        PMID: 18285291     DOI: 10.1300/j052v26n03_02

Source DB:  PubMed          Journal:  J Nutr Elder        ISSN: 0163-9366


  17 in total

Review 1.  Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.

Authors:  David B Hogan
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

Review 2.  PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

Authors:  Taiji Tsunemi; Albert R La Spada
Journal:  Prog Neurobiol       Date:  2011-11-09       Impact factor: 11.685

3.  Change in body mass index before and after Alzheimer's disease onset.

Authors:  Yian Gu; Nikolaos Scarmeas; Stephanie Cosentino; Jason Brandt; Marilyn Albert; Deborah Blacker; Bruno Dubois; Yaakov Stern
Journal:  Curr Alzheimer Res       Date:  2014-05       Impact factor: 3.498

4.  Common neurodegenerative disorders in the perioperative setting: Recommendations for screening from the Society for Perioperative Assessment and Quality Improvement (SPAQI).

Authors:  Margaret Wiggins; Franchesca Arias; Richard D Urman; Deborah C Richman; Bobbie Jean Sweitzer; Angela F Edwards; Melissa J Armstrong; Anita Chopra; David J Libon; Catherine Price
Journal:  Perioper Care Oper Room Manag       Date:  2020-02-05

Review 5.  Medical foods for Alzheimer's disease.

Authors:  Raj C Shah
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

6.  Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.

Authors:  Michael L Alosco; Jonathan Duskin; Lilah M Besser; Brett Martin; Christine E Chaisson; John Gunstad; Neil W Kowall; Ann C McKee; Robert A Stern; Yorghos Tripodis
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Health and nutritional promotion program for patients with dementia (NutriAlz Study): design and baseline data.

Authors:  A Salva; S Andrieu; E Fernandez; E J Schiffrin; J Moulin; B Decarli; Y Guigoz; B Vellas
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

8.  Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer's Disease among Older Adults in the United States, 2002-2012.

Authors:  May A Beydoun; Hind A Beydoun; Alyssa A Gamaldo; Ola S Rostant; Greg A Dore; Alan B Zonderman; Shaker M Eid
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 9.  Weight loss in neurodegenerative disorders.

Authors:  N A Aziz; M A van der Marck; H Pijl; M G M Olde Rikkert; B R Bloem; R A C Roos
Journal:  J Neurol       Date:  2009-01-22       Impact factor: 4.849

10.  Metabolic changes over the course of aging in a mouse model of tau deposition.

Authors:  Aurélie Joly-Amado; Karisa S Serraneau; Milene Brownlow; Caralina Marín de Evsikova; John R Speakman; Marcia N Gordon; Dave Morgan
Journal:  Neurobiol Aging       Date:  2016-04-25       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.